CIZ Company Description

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, develops an immunoassay test for the CIZ1B cancer biomarker for the early detection of lung cancer in the United Kingdom.

The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.

Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

Cizzle Biotechnology Holdings Plc

Country	United Kingdom
Industry	Biotechnology
Sector	Healthcare
Employees	4

Contact Details

Address: 60 Gracechurch Street London, EC3V 0HR United Kingdom
Website	cizzlebiotechnology.com

Stock Details

Ticker Symbol	CIZ
Exchange	London Stock Exchange
Fiscal Year	January - December
Reporting Currency	GBP
ISIN Number	GB00BNG2VN02
SIC Code	2835

Key Executives

Name	Position
Dr. Allan John Syms	Executive Chairman
Prof. Dawn Coverley	Founder and Independent Non-Executive Director
Nigel R. Lee	Finance Director and Executive Director